Literature DB >> 21661417

STAT3 and beta-catenin signaling pathway may affect GSK-3beta expression in hepatocellular carcinoma.

Xin-Hong Wang1, Xiang-Wei Meng, Hui Xing, Bo Qu, Ming-Zi Han, Jing Chen, Yu-Jing Fan, Cheng-Qian Lu, Zhi-Wu Lu.   

Abstract

BACKGROUND/AIMS: To study the correlation and significance of beta-catenin, STAT3 and GSK-3beta signaling pathway in hepatocellular carcinoma (HCC).
METHODOLOGY: The HCC cell line HepG2 was transfected with small interfering RNA (siRNA) directed against 8-catenin or STAT3. After 72 and 96h, protein was extracted and the protein expression of beta-catenin, STAT3, and GSK-3beta was detected by Western blot analysis.
RESULTS: After siRNA directed against beta-catenin was transfected into HepG2 cells, beta-catenin protein expression was decreased at 72 and 96h, GSK-3beta and p-GSK-3beta protein expression increased gradually at 72 and 96h, and STAT3 protein expression showed no change following transfection. After siRNA directed against STAT3 was transfected into HepG2 cells, STAT3 protein expression was decreased at 72 and 96h and beta-catenin, GSK-3beta and p-GSK-3beta protein expression all increased at 72h and decreased at 96 h after transfection.
CONCLUSION: In HCC, the beta-catenin signaling pathway may regulate GSK-3beta protein expression and the STAT3 signaling pathway may regulate beta-catenin and GSK-3beta protein expression, thereby playing key roles during HCC genesis and development.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21661417

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  6 in total

Review 1.  Wnt/beta-catenin signaling in glioma.

Authors:  Kailiang Zhang; Junxia Zhang; Lei Han; Peiyu Pu; Chunsheng Kang
Journal:  J Neuroimmune Pharmacol       Date:  2012-03-28       Impact factor: 4.147

2.  Unique genome-wide map of TCF4 and STAT3 targets using ChIP-seq reveals their association with new molecular subtypes of glioblastoma.

Authors:  Jun-Xia Zhang; Jing Zhang; Wei Yan; Ying-Yi Wang; Lei Han; Xiao Yue; Ning Liu; Yong-Ping You; Tao Jiang; Pei-Yu Pu; Chun-Sheng Kang
Journal:  Neuro Oncol       Date:  2013-01-07       Impact factor: 12.300

3.  Embelin suppresses dendritic cell functions and limits autoimmune encephalomyelitis through the TGF-β/β-catenin and STAT3 signaling pathways.

Authors:  Zhenyi Xue; Zhenzhen Ge; Kai Zhang; Rui Sun; Juhong Yang; Rong Han; Meiyu Peng; Yan Li; Wen Li; Da Zhang; Junwei Hao; Yurong Da; Zhi Yao; Rongxin Zhang
Journal:  Mol Neurobiol       Date:  2013-11-21       Impact factor: 5.590

4.  STAT3 Potentiates SIAH-1 Mediated Proteasomal Degradation of β-Catenin in Human Embryonic Kidney Cells.

Authors:  Minkyung Shin; Eun Hee Yi; Byung-Hak Kim; Jae-Cheon Shin; Jung Youl Park; Chung-Hyun Cho; Jong-Wan Park; Kang-Yell Choi; Sang-Kyu Ye
Journal:  Mol Cells       Date:  2016-11-18       Impact factor: 5.034

5.  Development of a Non-Coding-RNA-based EMT/CSC Inhibitory Nanomedicine for In Vivo Treatment and Monitoring of HCC.

Authors:  Ruomi Guo; Zhiqiang Wu; Jing Wang; Qingling Li; Shunli Shen; Weiwei Wang; Luyao Zhou; Wei Wang; Zhong Cao; Yu Guo
Journal:  Adv Sci (Weinh)       Date:  2019-03-07       Impact factor: 16.806

6.  Pomegranate Bioactive Constituents Suppress Cell Proliferation and Induce Apoptosis in an Experimental Model of Hepatocellular Carcinoma: Role of Wnt/ β -Catenin Signaling Pathway.

Authors:  Deepak Bhatia; Roslin J Thoppil; Animesh Mandal; Karishma A Samtani; Altaf S Darvesh; Anupam Bishayee
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-28       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.